{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:18:04Z","timestamp":1793812684382,"version":"4.6.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Maruho Co., Ltd"},{"DOI":"10.13039\/10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC-PC-13050"],"award-info":[{"award-number":["MC-PC-13050"]}],"id":[{"id":"10.13039\/10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S024409\/1"],"award-info":[{"award-number":["MR\/S024409\/1"]}],"id":[{"id":"10.13039\/10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human papillomavirus (HPV) is associated with 5% of all cancers globally at a range of body sites, including cervix, anus, penis, vagina, vulva, and oropharynx. These cancers claim\u2009&gt;\u2009400,000 lives annually. The persistent infection of HPV and the function of viral oncogenes are the primary causes of HPV-related cancers. However, only some HPV-infected persons or infected lesions will progress to cancer, and the burden of HPV-associated cancer varies widely according to gender and the part of the body infected. The dissimilarity in infection rates at different sites can explain only a small part of the differences observed. Much responsibility likely sits with contributions of specific epithelial cells and the cellular microenvironment at infected sites to the process of malignant transformation, both of which affect the regulation of viral gene expression and the viral life cycle. By understanding the biology of these epithelial sites, better diagnosis\/treatment\/management of HPV-associated cancer and\/or pre-cancer lesions will be provided.<\/jats:p>","DOI":"10.1007\/s10147-023-02340-y","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T04:03:10Z","timestamp":1684382590000},"page":"956-964","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3270-0592","authenticated-orcid":false,"given":"Nagayasu","family":"Egawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"2340_CR1","first-page":"455","volume":"42","author":"JF Fraumeni Jr","year":"1969","unstructured":"Fraumeni JF Jr, Lloyd JW, Smith EM et al (1969) Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in women. J Natl Cancer Inst 42:455\u2013468","journal-title":"J Natl Cancer Inst"},{"key":"2340_CR2","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","volume":"80","author":"M Durst","year":"1983","unstructured":"Durst M, Gissmann L, Ikenberg H et al (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 80:3812\u20133815","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2340_CR3","doi-asserted-by":"publisher","first-page":"26s","DOI":"10.1038\/jid.1984.16","volume":"83","author":"L Gissmann","year":"1984","unstructured":"Gissmann L, Boshart M, Durst M et al (1984) Presence of human papillomavirus in genital tumors. J Invest Dermatol 83:26s\u201328s","journal-title":"J Invest Dermatol"},{"key":"2340_CR4","doi-asserted-by":"crossref","unstructured":"Martel Cd, Plummer M, Vignat J,  et al . 2017. Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer 141.","DOI":"10.1002\/ijc.30716"},{"key":"2340_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2022.106960","volume":"156","author":"Vorsters A, Bosch FX, Poljak M, Waheed DE, Stanley M, Garland SM, Prevention HPV, Control B, the International Papillomavirus S","year":"2022","unstructured":"Vorsters A, Bosch FX, Poljak M,  et al , Prevention HPV, Control B, the International Papillomavirus S (2022) HPV prevention and control - The way forward. Prev Med 156:106960","journal-title":"Prev Med"},{"issue":"Suppl 1","key":"2340_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/rmv.1822","volume":"25","author":"J Doorbar","year":"2015","unstructured":"Doorbar J, Egawa N, Griffin H et al (2015) Human papillomavirus molecular biology and disease association. Rev Med Virol 25(Suppl 1):2\u201323","journal-title":"Rev Med Virol"},{"key":"2340_CR7","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/v7072802","volume":"7","author":"N Egawa","year":"2015","unstructured":"Egawa N, Egawa K, Griffin H et al (2015) Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia. Viruses 7:3863\u20133890","journal-title":"Viruses"},{"key":"2340_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2013.05.012","volume":"445","author":"K Van Doorslaer","year":"2013","unstructured":"Van Doorslaer K (2013) Evolution of the papillomaviridae. Virology 445:11\u201320","journal-title":"Virology"},{"key":"2340_CR9","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"2340_CR10","doi-asserted-by":"crossref","unstructured":"Harden ME, Munger K. 2017. Human papillomavirus molecular biology, vol 772.","DOI":"10.1016\/j.mrrev.2016.07.002"},{"key":"2340_CR11","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1128\/jvi.63.10.4417-4421.1989","volume":"63","author":"K Munger","year":"1989","unstructured":"Munger K, Phelps WC, Bubb V et al (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417\u20134421","journal-title":"J Virol"},{"key":"2340_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.virol.2011.10.012","volume":"422","author":"TG Magaldi","year":"2012","unstructured":"Magaldi TG, Almstead LL, Bellone S et al (2012) Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology 422:114\u2013124","journal-title":"Virology"},{"key":"2340_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"2340_CR14","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1038\/sj.onc.1202223","volume":"17","author":"M Thomas","year":"1998","unstructured":"Thomas M, Banks L (1998) Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17:2943\u20132954","journal-title":"Oncogene"},{"key":"2340_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM et al (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129\u20131136","journal-title":"Cell"},{"key":"2340_CR16","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.1073\/pnas.1435900100","volume":"100","author":"T Veldman","year":"2003","unstructured":"Veldman T, Liu X, Yuan H et al (2003) Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Natl Acad Sci U S A 100:8211\u20138216","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2340_CR17","doi-asserted-by":"publisher","first-page":"9852","DOI":"10.1128\/JVI.77.18.9852-9861.2003","volume":"77","author":"HR McMurray","year":"2003","unstructured":"McMurray HR, McCance DJ (2003) Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol 77:9852\u20139861","journal-title":"J Virol"},{"key":"2340_CR18","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1101\/gad.1214704","volume":"18","author":"L Gewin","year":"2004","unstructured":"Gewin L, Myers H, Kiyono T et al (2004) Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6\/E6-AP complex. Genes Dev 18:2269\u20132282","journal-title":"Genes Dev"},{"key":"2340_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.virol.2013.04.026","volume":"445","author":"SB Vande Pol","year":"2013","unstructured":"Vande Pol SB, Klingelhutz AJ (2013) Papillomavirus E6 oncoproteins. Virology 445:115\u2013137","journal-title":"Virology"},{"key":"2340_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.coviro.2021.09.011","volume":"51","author":"M Thomas","year":"2021","unstructured":"Thomas M, Banks L (2021) The biology of papillomavirus PDZ associations: what do they offer papillomaviruses? Curr Opin Virol 51:119\u2013126","journal-title":"Curr Opin Virol"},{"key":"2340_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","volume":"445","author":"A Roman","year":"2013","unstructured":"Roman A, Munger K (2013) The papillomavirus E7 proteins. Virology 445:138\u2013168","journal-title":"Virology"},{"key":"2340_CR22","first-page":"7075","volume":"62","author":"S Duensing","year":"2002","unstructured":"Duensing S, Munger K (2002) The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62:7075\u20137082","journal-title":"Cancer Res"},{"key":"2340_CR23","doi-asserted-by":"publisher","first-page":"12331","DOI":"10.1128\/JVI.77.22.12331-12335.2003","volume":"77","author":"S Duensing","year":"2003","unstructured":"Duensing S, Munger K (2003) Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol 77:12331\u201312335","journal-title":"J Virol"},{"key":"2340_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ijc.11691","volume":"109","author":"S Duensing","year":"2004","unstructured":"Duensing S, Munger K (2004) Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109:157\u2013162","journal-title":"Int J Cancer"},{"key":"2340_CR25","doi-asserted-by":"crossref","unstructured":"Incassati A, Patel D, McCance DJ. 2006. Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Oncogene 25:pp2444\u20132451.","DOI":"10.1038\/sj.onc.1209276"},{"key":"2340_CR26","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","volume":"12","author":"LV Ronco","year":"1998","unstructured":"Ronco LV, Karpova AY, Vidal M et al (1998) Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061\u20132072","journal-title":"Genes Dev"},{"key":"2340_CR27","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1074\/jbc.275.10.6764","volume":"275","author":"JS Park","year":"2000","unstructured":"Park JS, Kim EJ, Kwon HJ et al (2000) Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275:6764\u20136769","journal-title":"J Biol Chem"},{"key":"2340_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/jir.2006.26.455","volume":"26","author":"A Antonsson","year":"2006","unstructured":"Antonsson A, Payne E, Hengst K et al (2006) The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation. J Interferon Cytokine Res 26:455\u2013461","journal-title":"J Interferon Cytokine Res"},{"key":"2340_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28310","volume":"95","author":"M Lou","year":"2023","unstructured":"Lou M, Huang D, Zhou Z et al (2023) DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation. J Med Virol 95:e28310","journal-title":"J Med Virol"},{"key":"2340_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1126\/science.aab3291","volume":"350","author":"L Lau","year":"2015","unstructured":"Lau L, Gray EE, Brunette RL et al (2015) DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway. Science 350:568\u2013571","journal-title":"Science"},{"key":"2340_CR31","doi-asserted-by":"publisher","first-page":"11372","DOI":"10.1128\/JVI.05279-11","volume":"85","author":"J Reiser","year":"2011","unstructured":"Reiser J, Hurst J, Voges M et al (2011) High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression. J Virol 85:11372\u201311380","journal-title":"J Virol"},{"key":"2340_CR32","doi-asserted-by":"publisher","first-page":"9486","DOI":"10.1128\/JVI.05007-11","volume":"85","author":"S Hong","year":"2011","unstructured":"Hong S, Mehta KP, Laimins LA (2011) Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol 85:9486\u20139494","journal-title":"J Virol"},{"key":"2340_CR33","doi-asserted-by":"crossref","unstructured":"Est\u00eav\u00e3o D, Costa NR, Gil da Costa RM et al (2019) Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy, vol 1862.","DOI":"10.1016\/j.bbagrm.2019.01.001"},{"key":"2340_CR34","doi-asserted-by":"crossref","unstructured":"Doorbar J. 2018. Host control of human papillomavirus infection and disease. Best Pract Res Clin Obstet Gynaecol 47:pp27\u201341.","DOI":"10.1016\/j.bpobgyn.2017.08.001"},{"key":"2340_CR35","doi-asserted-by":"crossref","unstructured":"Gravitt PE, Winer RL. 2017. Natural History of HPV Infection across the Lifespan: Role of Viral Latency. Viruses 9.","DOI":"10.3390\/v9100267"},{"key":"2340_CR36","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1056\/NEJMoa035419","volume":"349","author":"GF Sawaya","year":"2003","unstructured":"Sawaya GF, McConnell KJ, Kulasingam SL et al (2003) Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 349:1501\u20131509","journal-title":"N Engl J Med"},{"key":"2340_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244\u2013265","journal-title":"J Clin Pathol"},{"key":"2340_CR38","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1067\/mob.2003.461","volume":"188","author":"Cox JT, Schiffman M, Solomon D, Group A-LTS","year":"2003","unstructured":"Cox JT, Schiffman M, Solomon D, Group A-LTS (2003) Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 188:1406\u20131412","journal-title":"Am J Obstet Gynecol"},{"key":"2340_CR39","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1172\/JCI57149","volume":"121","author":"PE Gravitt","year":"2011","unstructured":"Gravitt PE (2011) The known unknowns of HPV natural history. J Clin Invest 121:4593\u20134599","journal-title":"J Clin Invest"},{"key":"2340_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","volume":"113","author":"PE Castle","year":"2009","unstructured":"Castle PE, Schiffman M, Wheeler CM et al (2009) Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 113:18\u201325","journal-title":"Obstet Gynecol"},{"key":"2340_CR41","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J et al (2007) Human papillomavirus and cervical cancer. Lancet 370:890\u2013907","journal-title":"Lancet"},{"key":"2340_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/path.2192","volume":"212","author":"M Pett","year":"2007","unstructured":"Pett M, Coleman N (2007) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212:356\u2013367","journal-title":"J Pathol"},{"key":"2340_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","volume":"68","author":"S Vinokurova","year":"2008","unstructured":"Vinokurova S, Wentzensen N, Kraus I et al (2008) Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 68:307\u2013313","journal-title":"Cancer Res"},{"key":"2340_CR44","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1128\/jvi.69.5.2989-2997.1995","volume":"69","author":"S Jeon","year":"1995","unstructured":"Jeon S, Allen-Hoffmann BL, Lambert PF (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69:2989\u20132997","journal-title":"J Virol"},{"key":"2340_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0042-6822(89)90107-4","volume":"172","author":"T Matsukura","year":"1989","unstructured":"Matsukura T, Koi S, Sugase M (1989) Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 172:63\u201372","journal-title":"Virology"},{"key":"2340_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.virol.2009.09.027","volume":"395","author":"M Ottinger","year":"2009","unstructured":"Ottinger M, Smith JA, Schweiger MR et al (2009) Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2. Virology 395:161\u2013171","journal-title":"Virology"},{"key":"2340_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1006\/excr.1997.3529","volume":"232","author":"S Khare","year":"1997","unstructured":"Khare S, Pater MM, Tang SC et al (1997) Effect of glucocorticoid hormones on viral gene expression, growth, and dysplastic differentiation in HPV16-immortalized ectocervical cells. Exp Cell Res 232:353\u2013360","journal-title":"Exp Cell Res"},{"key":"2340_CR48","first-page":"5","volume":"81","author":"R Mittal","year":"1993","unstructured":"Mittal R, Tsutsumi K, Pater A et al (1993) Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones. Obstet Gynecol 81:5\u201312","journal-title":"Obstet Gynecol"},{"key":"2340_CR49","doi-asserted-by":"crossref","unstructured":"Kyo S, Inoue M, Hayasaka N,  et al . 1994. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 200:pp130\u2013139.","DOI":"10.1006\/viro.1994.1171"},{"key":"2340_CR50","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/QAD.0000000000000382","volume":"28","author":"Hleyhel M, Hleyhel M, Bouvier AM, et al , Cancer Risk Group of the French Hospital Database on HIV","year":"2014","unstructured":"Hleyhel M, Hleyhel M, Bouvier AM,  et al , Cancer Risk Group of the French Hospital Database on HIV (2014) Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort. AIDS 28:2109\u20132118","journal-title":"AIDS"},{"key":"2340_CR51","doi-asserted-by":"publisher","first-page":"E711","DOI":"10.1002\/ijc.29209","volume":"136","author":"PA Dugue","year":"2015","unstructured":"Dugue PA, Rebolj M, Hallas J et al (2015) Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: population-based cohort study. Int J Cancer 136:E711\u2013E719","journal-title":"Int J Cancer"},{"key":"2340_CR52","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","volume":"9","author":"D Stelzle","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK et al (2021) Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health 9:e161\u2013e169","journal-title":"Lancet Glob Health"},{"key":"2340_CR53","first-page":"1","volume":"90","author":"Humans IWGotEoCRt.","year":"2007","unstructured":"Humans IWGotEoCRt. (2007) Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 90:1\u2013636","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"2340_CR54","doi-asserted-by":"crossref","unstructured":"Castle PE. 2008. How does tobacco smoke contribute to cervical carcinogenesis? J Virol 82:6084\u20135; author reply 6085\u20136.","DOI":"10.1128\/JVI.00103-08"},{"key":"2340_CR55","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/jnci\/89.12.868","volume":"89","author":"B Prokopczyk","year":"1997","unstructured":"Prokopczyk B, Cox JE, Hoffmann D et al (1997) Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 89:868\u2013873","journal-title":"J Natl Cancer Inst"},{"key":"2340_CR56","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","volume":"361","author":"JS Smith","year":"2003","unstructured":"Smith JS, Green J, Berrington de Gonzalez A et al (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361:1159\u20131167","journal-title":"Lancet"},{"key":"2340_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ijc.20257","volume":"111","author":"JS Smith","year":"2004","unstructured":"Smith JS, Bosetti C, Munoz N et al (2004) Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 111:431\u2013439","journal-title":"Int J Cancer"},{"key":"2340_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semcancer.2022.03.005","volume":"86","author":"M Kyrgiou","year":"2022","unstructured":"Kyrgiou M, Moscicki AB (2022) Vaginal microbiome and cervical cancer. Semin Cancer Biol 86:189\u2013198","journal-title":"Semin Cancer Biol"},{"key":"2340_CR59","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pvr.2019.04.005","volume":"7","author":"J Doorbar","year":"2019","unstructured":"Doorbar J, Griffin H (2019) Refining our understanding of cervical neoplasia and its cellular origins. Papillomavirus Res 7:176\u2013179","journal-title":"Papillomavirus Res"},{"key":"2340_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrc.2018.11","volume":"18","author":"CR Leemans","year":"2018","unstructured":"Leemans CR, Snijders PJF, Brakenhoff RH (2018) The molecular landscape of head and neck cancer. Nat Rev Cancer 18:269\u2013282","journal-title":"Nat Rev Cancer"},{"key":"2340_CR61","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41416-019-0602-7","volume":"122","author":"ME Sabatini","year":"2020","unstructured":"Sabatini ME, Chiocca S (2020) Human papillomavirus as a driver of head and neck cancers. Br J Cancer 122:306\u2013314","journal-title":"Br J Cancer"},{"key":"2340_CR62","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/infdis\/jix333","volume":"216","author":"MD Ryser","year":"2017","unstructured":"Ryser MD, Rositch A, Gravitt PE (2017) Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution. J Infect Dis 216:604\u2013611","journal-title":"J Infect Dis"},{"key":"2340_CR63","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","volume":"76","author":"AG Schache","year":"2016","unstructured":"Schache AG, Powell NG, Cuschieri KS et al (2016) HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology. Cancer Res 76:6598\u20136606","journal-title":"Cancer Res"},{"key":"2340_CR64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jamaoncol.2016.3067","volume":"3","author":"G D'Souza","year":"2017","unstructured":"D\u2019Souza G, Westra WH, Wang SJ et al (2017) Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method. JAMA Oncol 3:169\u2013177","journal-title":"JAMA Oncol"},{"key":"2340_CR65","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/ijc.24215","volume":"124","author":"BE Hoots","year":"2009","unstructured":"Hoots BE, Palefsky JM, Pimenta JM et al (2009) Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 124:2375\u20132383","journal-title":"Int J Cancer"},{"key":"2340_CR66","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","volume":"386","author":"Palefsky JM, Lee JY, Jay N, Goldstone SE, Darragh TM, Dunlevy HA, Rosa-Cunha I, Arons A, Pugliese JC, Vena D, Sparano JA, Wilkin TJ, Bucher G, Stier EA, Tirado Gomez M, Flowers L, Barroso LF, Mitsuyasu RT, Lensing SY, Logan J, Aboulafia DM, Schouten JT, de la Ossa J, Levine R, Korman JD, Hagensee M, Atkinson TM, Einstein MH, Cracchiolo BM, Wiley D, Ellsworth GB, Brickman C, Berry-Lawhorn JM, Group AI","year":"2022","unstructured":"Palefsky JM, Lee JY, Jay N,  et al  (2022) Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer. N Engl J Med 386:2273\u20132282","journal-title":"N Engl J Med"},{"key":"2340_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204162","volume":"13","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang Y, Zhang Z (2018) Prevalence of human papillomavirus and its prognostic value in vulvar cancer: a systematic review and meta-analysis. PLoS ONE 13:e0204162","journal-title":"PLoS ONE"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02340-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-023-02340-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02340-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T17:02:35Z","timestamp":1763226155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-023-02340-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1007\/s10147-023-02340-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original publication has been updated to correct the funding information.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Egawa reports grants from Maruho Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}